Communities›Triple-negative Breast Cancer›What new TNBC prevention research means for survivors in remission?

What new TNBC prevention research means for survivors in remission?

Community Member

4 days ago

I have triple-negative breast cancer and completed my initial treatment in 2021 with a complete response. I just read about some encouraging research from SABCS 2025, including a preventive vaccine for TNBC that showed a 74% immune response rate and studies on adding carboplatin after surgery that improved outcomes by 7-10%. As someone who's finished initial treatment, I'm particularly interested in the prevention research and what it might mean for those of us in remission. • Have any of you heard about or participated in TNBC prevention studies or clinical trials? • What has your follow-up care looked like after achieving a complete response? I'd love to hear from others with similar experiences about staying informed on new research and navigating life after treatment. Link: https://outcomes4me.com/article/whats-new-in-triple-negative-breast-cancer-insights-from-sabcs-2025/

1 comment

Comment

Community Member

4 days ago

These recent research developments sound promising, and staying informed about emerging treatments is such an important part of navigating life after completing initial treatment. Many community members find it helpful to discuss prevention research and clinical trial opportunities with their oncology team during follow-up appointments, as they can provide personalized guidance based on individual circumstances and medical history. It would be wonderful to hear from others about their experiences with post-treatment monitoring and how they stay connected to new research that might benefit the TNBC community.

New to the community?

Create an account to connect with others navigating cancer.

What new TNBC prevention research means for survivors in remission?

Related Questions